Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019
Abstract Background Tracheal, bronchus, and lung (TBL) cancer is the third most common and lethal type of cancer worldwide. Glucose metabolism disorders, as represented by high fasting plasma glucose (HFPG), increase the risk of development and worsen the prognosis of TBL cancer. This study aimed to...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Series: | Journal of Diabetes |
| Subjects: | |
| Online Access: | https://doi.org/10.1111/1753-0407.13499 |
| _version_ | 1797246882303442944 |
|---|---|
| author | Minmin Wang Jingyi Liu Jia Wang Yinzi Jin Zhi‐Jie Zheng |
| author_facet | Minmin Wang Jingyi Liu Jia Wang Yinzi Jin Zhi‐Jie Zheng |
| author_sort | Minmin Wang |
| collection | DOAJ |
| description | Abstract Background Tracheal, bronchus, and lung (TBL) cancer is the third most common and lethal type of cancer worldwide. Glucose metabolism disorders, as represented by high fasting plasma glucose (HFPG), increase the risk of development and worsen the prognosis of TBL cancer. This study aimed to evaluate the global disease burden of TBL cancer attributable to HFPG. Methods The TBL cancer burden attributable to HFPG was estimated based on a modeling strategy using the Global Burden of Disease Study 2019. The disease burden globally and by regions, countries, development levels, age groups, and sexes were also evaluated with the indicators of death, disability‐adjusted life years, years of life lost, and years lived with disability. The estimated annual percentage change (EAPC) was calculated by regression model to show the temporal trend. Results In 2019, approximately 8% of the total TBL cancer burden was attributable to HFPG. The HFPG‐attributable TBL cancer burden increased globally from 1990 to 2019 with the EAPC of 0.98% per year. The burden was positively associated with social development levels, and the global burden was three times greater in men than in women. HFPG‐attributable TBL cancer burden increased with age and peaked at above 70 years of age. Conclusions The findings highlight the effect and burden of glucose disorders, as represented by HFPG on TBL cancer burden. Integrated cancer prevention and control measures are needed, with control of glucose disorders as one of the key elements. |
| first_indexed | 2024-04-24T19:49:51Z |
| format | Article |
| id | doaj.art-bcbdf30d8d0a412ba58a393da4534198 |
| institution | Directory Open Access Journal |
| issn | 1753-0393 1753-0407 |
| language | English |
| last_indexed | 2024-04-24T19:49:51Z |
| publishDate | 2024-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes |
| spelling | doaj.art-bcbdf30d8d0a412ba58a393da45341982024-03-25T02:02:40ZengWileyJournal of Diabetes1753-03931753-04072024-03-01163n/an/a10.1111/1753-0407.13499Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019Minmin Wang0Jingyi Liu1Jia Wang2Yinzi Jin3Zhi‐Jie Zheng4Department of Global Health, School of Public Health Peking University Beijing ChinaSchool of Nursing Peking University Beijing ChinaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing ChinaDepartment of Global Health, School of Public Health Peking University Beijing ChinaDepartment of Global Health, School of Public Health Peking University Beijing ChinaAbstract Background Tracheal, bronchus, and lung (TBL) cancer is the third most common and lethal type of cancer worldwide. Glucose metabolism disorders, as represented by high fasting plasma glucose (HFPG), increase the risk of development and worsen the prognosis of TBL cancer. This study aimed to evaluate the global disease burden of TBL cancer attributable to HFPG. Methods The TBL cancer burden attributable to HFPG was estimated based on a modeling strategy using the Global Burden of Disease Study 2019. The disease burden globally and by regions, countries, development levels, age groups, and sexes were also evaluated with the indicators of death, disability‐adjusted life years, years of life lost, and years lived with disability. The estimated annual percentage change (EAPC) was calculated by regression model to show the temporal trend. Results In 2019, approximately 8% of the total TBL cancer burden was attributable to HFPG. The HFPG‐attributable TBL cancer burden increased globally from 1990 to 2019 with the EAPC of 0.98% per year. The burden was positively associated with social development levels, and the global burden was three times greater in men than in women. HFPG‐attributable TBL cancer burden increased with age and peaked at above 70 years of age. Conclusions The findings highlight the effect and burden of glucose disorders, as represented by HFPG on TBL cancer burden. Integrated cancer prevention and control measures are needed, with control of glucose disorders as one of the key elements.https://doi.org/10.1111/1753-0407.13499global burden of diseasehigh fasting plasma glucosetracheal, bronchus, and lung cancer |
| spellingShingle | Minmin Wang Jingyi Liu Jia Wang Yinzi Jin Zhi‐Jie Zheng Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 Journal of Diabetes global burden of disease high fasting plasma glucose tracheal, bronchus, and lung cancer |
| title | Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 |
| title_full | Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 |
| title_fullStr | Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 |
| title_full_unstemmed | Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 |
| title_short | Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019 |
| title_sort | global regional and national burden of tracheal bronchus and lung cancers attributable to high fasting plasma glucose a systematic analysis of global burden of disease 2019 |
| topic | global burden of disease high fasting plasma glucose tracheal, bronchus, and lung cancer |
| url | https://doi.org/10.1111/1753-0407.13499 |
| work_keys_str_mv | AT minminwang globalregionalandnationalburdenoftrachealbronchusandlungcancersattributabletohighfastingplasmaglucoseasystematicanalysisofglobalburdenofdisease2019 AT jingyiliu globalregionalandnationalburdenoftrachealbronchusandlungcancersattributabletohighfastingplasmaglucoseasystematicanalysisofglobalburdenofdisease2019 AT jiawang globalregionalandnationalburdenoftrachealbronchusandlungcancersattributabletohighfastingplasmaglucoseasystematicanalysisofglobalburdenofdisease2019 AT yinzijin globalregionalandnationalburdenoftrachealbronchusandlungcancersattributabletohighfastingplasmaglucoseasystematicanalysisofglobalburdenofdisease2019 AT zhijiezheng globalregionalandnationalburdenoftrachealbronchusandlungcancersattributabletohighfastingplasmaglucoseasystematicanalysisofglobalburdenofdisease2019 |